期刊
CELL REPORTS
卷 16, 期 12, 页码 3373-3387出版社
CELL PRESS
DOI: 10.1016/j.celrep.2016.08.053
关键词
-
类别
资金
- Morris K. Udall Parkinson's Disease Center of Excellence [NIH NS053488]
- NIH [NS088322, T32-AG000255]
- Ofer Nimerovsky Family Fund
- Jeff and Anne Keefer Fund
The accumulation and propagation of misfolded a-synuclein (alpha-Syn) is a central feature of Parkinson's disease and other synucleinopathies. Molecular compatibility between a fibrillar seed and its native protein state is a major determinant of amyloid self-replication. We show that cross-seeded aggregation of human (Hu) and mouse (Ms) alpha-Syn is bidirectionally restricted. Although fibrils formed by Hu-Msa-Syn chimeric mutants can overcome this inhibition in cell-free systems, sequence homology poorly predicts their efficiency in inducing alpha-Syn pathology in primary neurons or after intracerebral injection into wild-type mice. Chimeric alpha-Syn fibrils demonstrate enhanced or reduced pathogenicities compared with wild-type Hu-or Ms-alpha-Syn fibrils. Furthermore, alpha-Syn mutants induced to polymerize by fibrillar seeds inherit the functional properties of their template, suggesting that transferable pathogenic and non-pathogenic states likely influence the initial engagement between exogenous alpha-Syn seeds and endogenous neuronal alpha-Syn. Thus, transmission of synucleinopathies is regulated by biological processes in addition to molecular compatibility.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据